Literature DB >> 13133810

The present status of radiotherapy and chemotherapy in the treatment of chronic leukaemia; a review.

M HULBERT.   

Abstract

Entities:  

Keywords:  CHEMOTHERAPY; LEUKEMIA/therapy; RADIOTHERAPY

Mesh:

Year:  1954        PMID: 13133810      PMCID: PMC2500625          DOI: 10.1136/pgmj.30.340.93

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

Authors:  A HADDOW; G M TIMMIS
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

2.  Bone marrow changes in patients with chronic leukemia treated by splenic X-irradiation; preliminary report.

Authors:  F W GUNZ
Journal:  Blood       Date:  1953-08       Impact factor: 22.113

3.  Chronic myeloid leukemia. II. A comparative analysis of the incidence and of the results of treatment of 56 cases.

Authors:  E M LEDLIE
Journal:  Br J Radiol       Date:  1953-06       Impact factor: 3.039

4.  Triethylene melamine in the treatment of neoplastic disease.

Authors:  R W RUNDLES; W B BARTON
Journal:  Blood       Date:  1952-05       Impact factor: 22.113

5.  A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.

Authors:  W B MATTHEWS
Journal:  Lancet       Date:  1950-05-13       Impact factor: 79.321

6.  THE EFFECT OF ETHYL URETHANE ANESTHESIA ON THE ACID-BASE EQUILIBRIUM AND CELL CONTENTS OF THE BLOOD.

Authors:  J A Hawkins; J B Murphy
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

7.  Ethyl carbamate (urethane) in the treatment of chronic myelocytic leukemia; results of a three-year study.

Authors:  T COOPER; C H WATKINS
Journal:  Med Clin North Am       Date:  1950-07       Impact factor: 5.456

8.  Discussion on the chemotherapy of the reticuloses.

Authors:  J F WILKINSON; A HADDOW; J D NABARRO
Journal:  Proc R Soc Med       Date:  1953-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.